8-K: USBC Boosts ATM Offering to $14.5M for Corporate Needs

Sentiment:

Capital Raise Update


USBC, Inc. announced an increase in its at-the-market equity offering program with JonesTrading to a maximum aggregate offering price of $14.5 million to fund general corporate purposes.

Capital raiseIncreased the maximum aggregate offering price under its Capital on Demand Sales Agreement from $5,000,000 to $14,500,000.The company has already sold 1,708,124 shares for gross proceeds of approximately $1,269,236 since December 31, 2024, under the initial program.The offer and sale of shares will be made through an at-the-market offering program with JonesTrading Institutional Services LLC as the sales agent.Net proceeds are intended for general corporate purposes, including working capital and capital expenditures.

Summary

  • Increased the maximum aggregate offering price under its Capital on Demand Sales Agreement with JonesTrading Institutional Services LLC from $5,000,000 to $14,500,000.
  • Since December 31, 2024, 1,708,124 shares of common stock have been sold under the Sales Agreement, generating gross proceeds of approximately $1,269,236.
  • As of September 4, 2025, USBC, Inc. has 384,234,130 outstanding shares of common stock.
  • Net proceeds from the offering are expected to be used primarily for general corporate purposes, including working capital and capital expenditures.

Sentiment

Score: 5

Explanation: The filing announces a capital raise, which provides necessary funding but also implies potential dilution for existing shareholders. It's a neutral event in terms of operational performance, but the need for external capital and the associated dilution can be viewed with mixed sentiment.

Positives

  • Secures additional capital flexibility, increasing the potential funding available through the ATM program by $9,500,000.
  • Provides a mechanism for ongoing funding for general corporate purposes, including working capital and capital expenditures, without a single large dilutive event.

Negatives

  • The increase in the ATM offering program suggests a continued need for external funding, potentially indicating insufficient internal cash generation.
  • Future sales of common stock under the program will result in dilution for existing shareholders.
  • The total number of shares to be sold and the exact proceeds are not determinable at this time, creating uncertainty regarding the extent of future dilution.

Risks

  • The total number of shares to be sold and the proceeds to the company are not determinable at this time, creating uncertainty regarding the extent of future dilution and capital raised.
  • Management will have significant discretion and flexibility in applying the net proceeds, which may not align with all shareholder expectations or lead to optimal capital allocation.
  • The offer and sale of additional common stock will result in dilution for existing shareholders.

Future Outlook

The company expects to use any net proceeds primarily for general corporate purposes, including working capital and capital expenditures. Management will have significant discretion and flexibility in applying these proceeds.

Management Comments

  • "Management will have significant discretion and flexibility in applying the net proceeds from the sale of these securities."

Industry Context

At-the-market (ATM) offerings are a common financing tool, particularly for growth-stage companies or those with fluctuating capital needs, allowing them to raise capital opportunistically without the significant upfront costs and market disruption of a traditional underwritten offering. This move by USBC, Inc. aligns with a broader trend of companies utilizing flexible equity financing to support ongoing operations and strategic initiatives.

Comparison to Industry Standards

  • The filing does not provide specific data points or benchmarks to allow for a direct comparison to industry-specific financial performance or project results of comparable companies.
  • The use of an ATM offering is a standard capital-raising mechanism, but the specific terms and the amount raised relative to market capitalization would be needed for a detailed comparative analysis.

Stakeholder Impact

  • Shareholders: Potential dilution of ownership percentage due to the issuance of new shares. Provides capital for company operations, which could support long-term value if effectively deployed.
  • Creditors: Improved liquidity and financial stability from additional capital could reduce credit risk.
  • Employees: Continued funding for operations may ensure job security and support growth initiatives.

Next Steps

  • Continue to offer and sell shares of common stock through the at-the-market offering program with JonesTrading Institutional Services LLC.
  • Utilize net proceeds for general corporate purposes, including working capital and capital expenditures.

Key Dates

DateDescription
December 22, 2023Company initially filed shelf registration statement on Form S-3 (File No. 333-276246).
January 5, 2024Post-Effective Amendment No. 1 to Form S-3 filed.
January 11, 2024Shelf registration statement on Form S-3 declared effective by the SEC.
December 31, 2024Prospectus supplement dated; Capital on Demand Sales Agreement entered into with JonesTrading Institutional Services LLC.
January 2, 2025Prospectus supplement dated December 31, 2024, filed with the SEC.
September 4, 2025Company determined to increase the amount available for sale under the Sales Agreement; outstanding shares of common stock reported as 384,234,130.
September 5, 2025Date of report (earliest event reported); Additional prospectus supplement filed; Opinion of Holland & Hart LLP dated.

Recommendation

hold

The increase in the ATM offering provides USBC, Inc. with necessary capital for general corporate purposes, including working capital and capital expenditures. While this secures funding, it also signals ongoing reliance on external financing and will result in dilution for existing shareholders. Without further operational or financial performance details, a 'hold' recommendation is appropriate, acknowledging both the benefit of capital infusion and the potential negative impact of dilution.

Keywords

USBC Inc, Know Labs, ATM offering, equity raise, capital raise, common stock, JonesTrading, SEC filing, Form 8-K, dilution, working capital, capital expenditures

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.